- MRK -0.64%
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Yahoo Finance · 2 weeks ago
Open | 130.58 |
High | 131.51 |
Low | 129.33 |
Mkt Cap | 328.13B |
P/E (TTM) | 145.56 |
Div & Yield | 3.08 & 2.38% |
Prev. Close | 130.38 |
52 Wk. Low | 99.14 |
52 Wk. High | 133.10 |
Related stocks
American multinational pharmaceutical company
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 15.78B | 8.90% ▲ |
Net Income | 4.76B | 68.80% ▲ |
Diluted EPS | 2.07 | 68.50% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $2.14 | - |
Q1 2024 | $1.87 | $2.07 |
Q4 2023 | -$0.11 | $0.03 |
S&P FuturesES=F | 5,209.00-3.75 (-0.07%) |
Dow FuturesYM=F | 39,119.00-76.00 (-0.19%) |
Nasdaq FuturesNQ=F | 18,179.25-7.25 (-0.04%) |
106.07-1.60% | |
Airbnb, Inc.ABNB | 157.90-1.20% |
17.85-0.78% |